MR imaging of neoplastic central nervous system lesions: review and recommendations for current practice (Q34053148)

30 July 2017

title

MR imaging of neoplastic central nervous system lesions: review and recommendations for current practice (English)

1 reference

30 July 2017

M Essig

1

1 reference

30 July 2017

N Anzalone

2

1 reference

30 July 2017

S E Combs

3

1 reference

30 July 2017

À Dörfler

4

1 reference

30 July 2017

S-K Lee

5

1 reference

30 July 2017

P Picozzi

6

1 reference

30 July 2017

A Rovira

7

1 reference

30 July 2017

M Weller

8

1 reference

30 July 2017

M Law

9

1 reference

30 July 2017

language of work or name

1 reference

20 October 2011

1 reference

American Journal of Neuroradiology

30 July 2017

published in

1 reference

30 July 2017

volume

33

1 reference

30 July 2017

issue

5

1 reference

30 July 2017

page(s)

803-817

1 reference

Contrast-enhanced magnetic resonance imaging of central nervous system tumors: agents, mechanisms, and applications

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2640

Principles of contrast enhancement in the evaluation of brain diseases: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2640

Central nervous system: review of clinical use of contrast media

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2640

Prevalence of acute adverse reactions to gadobutrol--a highly concentrated macrocyclic gadolinium chelate: review of 14,299 patients from observational trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2640

Assessment of adverse reaction rates to a newly approved MRI contrast agent: review of 23,553 administrations of gadobenate dimeglumine

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2640

Clinical Safety and Diagnostic Value of the Gadolinium Chelate Gadoterate Meglumine (Gd-DOTA)

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2640

Diffusion tensor imaging in cerebral tumor diagnosis and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2640

The effectiveness of implementing a care pathway for femoral neck fracture in older people: a prospective controlled before and after study

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2640

Perfusion MR imaging: basic principles and clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2640

Reproducibility of quantitative dynamic contrast-enhanced MRI in newly presenting glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2640

Magnetic resonance perfusion and permeability imaging in brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2640

Gliomas: predicting time to progression or survival with cerebral blood volume measurements at dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2640

Simultaneous mapping of blood volume and endothelial permeability surface area product in gliomas using iterative analysis of first-pass dynamic contrast enhanced MRI data.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2640

Quantitative estimation of microvascular permeability in human brain tumors: correlation of dynamic Gd-DTPA-enhanced MR imaging with histopathologic grading

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2640

Diffusion-weighted MR imaging of the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2640

Diffusion-weighted MR imaging derived apparent diffusion coefficient is predictive of clinical outcome in primary central nervous system lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2640

Grading astrocytic tumors by using apparent diffusion coefficient parameters: superiority of a one- versus two-parameter pilot method

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2640

Imaging glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2640

Analysis of volume MRI and MR spectroscopic imaging data for the evaluation of patients with brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2640

Increased choline signal coinciding with malignant degeneration of cerebral gliomas: a serial proton magnetic resonance spectroscopy imaging study

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2640

MR perfusion imaging of the brain: techniques and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2640

Clinical applications of PET in brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2640

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2640

Vanishing Balò-like lesions in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2640

Use of serial proton magnetic resonance spectroscopy to differentiate low grade glioma from tumefactive plaque in a patient with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2640

Spectroscopic magnetic resonance imaging of a tumefactive demyelinating lesion

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2640

In vivo differentiation of astrocytic brain tumors and isolated demyelinating lesions of the type seen in multiple sclerosis using 1H magnetic resonance spectroscopic imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2640

Proton MR spectroscopy improves discrimination between tumor and pseudotumoral lesion in solid brain masses

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2640

High-grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2640

The 2007 WHO classification of tumours of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2640

Gliomas: classification with MR imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2640

Computed tomography and histologic limits in glial neoplasms: tumor types and selection for volumetric resection

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2640

Biopsy targeting gliomas: do functional imaging techniques identify similar target areas?

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2640

Diffusion tensor tractography in patients with cerebral tumors: a helpful technique for neurosurgical planning and postoperative assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2640

Neurological complications

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2640

Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2640

NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2640

Current controversies in the radiotherapeutic management of adult low-grade glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2640

Presidential symposium on low-grade glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2640

Radiation oncology in brain tumors: current approaches and clinical trials in progress.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2640

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2640

MR-spectroscopy guided target delineation for high-grade gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2640

Comparison of T2 and FLAIR imaging for target delineation in high grade gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2640

In Vivo Correlation of Tumor Blood Volume and Permeability with Histologic and Molecular Angiogenic Markers in Gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2640

Response criteria for phase II studies of supratentorial malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2640

Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2640

End point assessment in gliomas: novel treatments limit usefulness of classical Macdonald's Criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2640

Pseudoprogression and pseudoresponse: challenges in brain tumor imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2640

Disease progression or pseudoprogression after concomitant radiochemotherapy treatment: pitfalls in neurooncology

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2640

Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2640

Hyperintensity in the subarachnoid space on FLAIR MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2640

Brain MRI lesion load at 1.5T and 3T versus clinical status in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2640

Higher sensitivity in the detection of inflammatory brain lesions in patients with clinically isolated syndromes suggestive of multiple sclerosis using high field MRI: an intraindividual comparison of 1.5 T with 3.0 T.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2640

Evaluation of gadobutrol, a macrocyclic, nonionic gadolinium chelate in a brain glioma model: comparison with gadoterate meglumine and gadopentetate dimeglumine at 1.5 T, combined with an assessment of field strength dependence, specifically 1.5 ver

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2640

Brain tumor enhancement in magnetic resonance imaging: comparison of signal-to-noise ratio (SNR) and contrast-to-noise ratio (CNR) at 1.5 versus 3 tesla.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2640

Brain tumor enhancement in MR imaging at 3 Tesla: comparison of SNR and CNR gain using TSE and GRE techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2640

32-channel 3 Tesla receive-only phased-array head coil with soccer-ball element geometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2640

96-Channel receive-only head coil for 3 Tesla: design optimization and evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2640

Effect of contrast dose and field strength in the magnetic resonance detection of brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2640

Gadobenate dimeglumine-enhanced magnetic resonance imaging of intracranial metastases: effect of dose on lesion detection and delineation

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2640

Dynamic contrast enhancement of experimental glioma an intra-individual comparative study to assess the optimal time delay

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2640

Stability of gadolinium-based magnetic resonance imaging contrast agents in human serum at 37 degrees C.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2640

Preclinical investigation to compare different gadolinium-based contrast agents regarding their propensity to release gadolinium in vivo and to trigger nephrogenic systemic fibrosis-like lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2640

Gadolinium - a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2640

How to compare the efficiency of albumin-bound and nonalbumin-bound contrast agents in vivo: the concept of dynamic relaxivity

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2640

Intraindividual comparison between gadopentetate dimeglumine and gadobutrol for magnetic resonance perfusion in normal brain and intracranial tumors at 3 Tesla.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2640

Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2640

Detection of cerebral metastases on magnetic resonance imaging: intraindividual comparison of gadobutrol with gadopentetate dimeglumine.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2640

Intraindividual comparison of gadobenate dimeglumine and gadobutrol for cerebral magnetic resonance perfusion imaging at 1.5 T.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2640

Phase III, randomized, double-blind, cross-over comparison of gadoteridol and gadopentetate dimeglumine in magnetic resonance imaging of patients with intracranial lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2640

Magnetic resonance imaging in patients with central nervous system pathology: a comparison of OptiMARK (Gd-DTPA-BMEA) and Magnevist (Gd-DTPA).

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2640

Diagnostic yield of double-dose gadobutrol in the detection of brain metastasis: intraindividual comparison with double-dose gadopentetate dimeglumine.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2640

Evaluation of intraaxial enhancing brain tumors on magnetic resonance imaging: intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine for visualization and assessment, and implications for surgical intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2640

Contrast enhancement of central nervous system lesions: multicenter intraindividual crossover comparative study of two MR contrast agents

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2640

Contrast-enhanced MR imaging of brain lesions: a large-scale intraindividual crossover comparison of gadobenate dimeglumine versus gadodiamide

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2640

Multicenter, double-blind, randomized, intra-individual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine in MRI of brain tumors at 3 tesla.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2640

A double-blind, comparative study of gadodiamide injection and gadopentetate dimeglumine in MRI of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2640

Comparative evaluation of lesion enhancement using 1 M gadobutrol vs. 2 conventional gadolinium chelates, all at a dose of 0.1 mmol/kg, in a rat brain tumor model at 3 T.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2640

In vivo measurement of gadolinium concentration in a rat glioma model by monochromatic quantitative computed tomography: comparison between gadopentetate dimeglumine and gadobutrol

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2640

Do highly concentrated gadolinium chelates improve MR brain perfusion imaging? Intraindividually controlled randomized crossover concentration comparison study of 0.5 versus 1.0 mol/L gadobutrol

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2640

A multi-centre longitudinal study comparing the sensitivity of monthly MRI after standard and triple dose gadolinium-DTPA for monitoring disease activity in multiple sclerosis. Implications for phase II clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2640

High-dose gadoteridol in MR imaging of intracranial neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2640

Sensitivity of immediate and delayed gadolinium-enhanced MRI after injection of 0.5 M and 1.0 M gadolinium chelates for detecting multiple sclerosis lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2640

Extracellular gadolinium-based contrast media: differences in diagnostic efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2640

Gd-enhanced MR imaging of brain metastases: Contrast as a function of dose and lesion size

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2640

Triple-dose versus single-dose gadoteridol in multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2640

Dose of contrast material in the MR imaging evaluation of central nervous system tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2640

Comparative studies of different gadolinium agents in brain tumors: differences between gadolinium chelates and their possible influence on imaging features.

21 January 2018

1 reference

https://api.crossref.org/works/10.3174%2FAJNR.A2640

21 January 2018

Identifiers

DOI

10.3174/AJNR.A2640

1 reference

30 July 2017

1 reference